News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Bladder Cancer Treatment
August 28, 2025
What Should Women Know About Bladder Cancer
Charles H. Weaver, MD
August 28, 2025
Overview of Bladder Cancer
Charles H. Weaver, MD
August 28, 2025
Personalized ctDNA MRD Testing Improves Outcomes in Muscle-Invasive Bladder Cancer
Charles H. Weaver, MD
August 28, 2025
Treatment of Stage II and III Bladder Cancer
Charles H. Weaver, MD
October 23, 2023
Padcev (enfortumab vedotin) Treatment for Bladder Cancer
Charles H. Weaver, MD
February 11, 2021
Opdivo Treatment of Bladder Cancer
Charles H. Weaver, MD
August 28, 2020
Treatment of Stage IV Bladder Cancer
Charles H. Weaver, MD
June 6, 2020
Keytruda Improves Survival of Advanced Bladder Cancer
Charles H. Weaver, MD
May 31, 2020
Avelumab Immunotherapy Approved for Bladder Cancer
Charles H. Weaver, MD
March 8, 2020
Imfinzi for Treatment of Urothelial Cancer
Charles H. Weaver, MD
October 10, 2019
Tecentriq Immunotherapy Provides Benefit in Advanced Bladder Cancer
Charles H. Weaver, MD
August 7, 2018
Balversa – Erdafitinib FDA Approved for Treatment of Advanced Bladder Cancer
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
